There are 10 different monoclonal antibodies to #SARSCoV2 in clinical trials. But we really need nanobodies, given by SQ self-injection or inhalation, that are cheap, more scalable, and practical. There are precedents for these by
The race to make COVID antibody therapies cheaper and more potent
“What you really want is something that is so amazingly potent that you need barely any" #mAbs #COVID19